Blood test for cancer recurrence could be introduced in a few years | Svenska Dagbladet

A groundbreaking Swedish study suggests a new blood test could revolutionize the detection of recurrent colon and rectal cancer. The test shows promise in identifying cancer recurrence far earlier than existing methods, potentially sparing patients from arduous and often unnecessary chemotherapy treatments.

Researchers found that the blood test can detect residual cancer cells or DNA fragments circulating in the bloodstream. This early warning system could significantly improve patient outcomes by enabling timely intervention when the disease is most treatable. The findings could lead to a paradigm shift in post-treatment monitoring for these cancer types.

If implemented, this diagnostic tool could become a standard part of follow-up care for patients diagnosed with colon and rectal cancer. The potential to avoid chemotherapy for those who do not have a recurrence represents a major advancement in patient care, reducing both the physical and psychological burden of cancer treatment.